Introduction
The philosophy of RCRS is to provide professional,
innovative and effective clinical trial solutions
through our highly capable and well trained
team of clinical research professionals. RCRS
works in close collaboration and co-operation
with clinical and hospital investigators and
regulatory agencies.
Experience
RCRS offers fully integrated drug development
services by an ACRP (Association of Clinical
Research Professionals) accredited staff.
RCRS has access to well-trained investigators
and sites and has considerable international
exposure by virtue of our global collaborations.
RCRS has gathered experience in the
following areas:
| Oncology
: |
Chemotherapy
with concurrent biological agent as 1st
line therapy in Non Small Cell Lung Cancer
(NSCLC), Recombinant agent in Renal Cell
Carcinoma, Recombinant agent as monotherapy
in NSCLC, Relapsed Refractory Multiple
Myeloma, Radiomodifier in Glioblastomas,
Cachexia in Cancer patients , Cachexia
in Pancreatic Cancer, Prostrate Cancer,
Head & Neck cancer and Breast Cancer. |
Infectious
Diseases : |
Methicillin Resistant Staphylococcus
Aureus infections, Aspergillosis, Severe
Sepsis
|
| Vaccines:
|
HIV, Tuberculosis, Rotavirus,
Anthrax, , Pediatric Hepatitis B and DTP
|
| Psychiatry
: |
Major Depressive Disorder,
Adolescent Schizophrenia, Severe Depression
and Epilepsy |
| Gynecology
: |
Sterilization by Chemical
Method |
| Endocrinology
: |
Oral Anti-Diabetics, Diabetic
Foot Ulcers, Dwarfism |
| Dermatology
: |
Plain and Interactive Wound
Cover, Deep Seated Wound Covers, Dose
Ranging Enzymatic Therapy for Debridement
in Burn Wounds |
| Hematology
: |
Chemotherapy Induced Neutropenia,
Anemia in Cervical Cancer |
| Gastroenterology
: |
Chronic Hepatitis B, Traveler's
Diarrhea, Crohn's Disease |
| Orthopedics
: |
NSAIDs in Osteoarthritis,
Herbal Formulation in Osteoarthritis |
| Ophthalmology
: |
Corneal Disorders, Conjunctival
Disorders, Chronic Blepharitis |
| Nephrology
: |
Probiotic in Chronic Renal
disease, End Stage Renal Disease |
| Neurology
: |
Probiotic in Chronic Renal
Disease, End Stage Renal Disease |
| Cardiovascular
: |
Cholesterol Lowering Agents,
Myocardial Infarction, Risk of Cardiovascular
disease, Angina |
| Respiratory
: |
Acute Exacerbation of Chronic
Bronchitis |
|
